Intervention Review

Toremifene versus tamoxifen for advanced breast cancer

  1. Chen Mao1,
  2. Zu-Yao Yang1,
  3. Ben-Fu He2,
  4. Shan Liu3,
  5. Jun-Hua Zhou3,
  6. Rong-Cheng Luo2,
  7. Qing Chen3,
  8. Jin Ling Tang4,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 1 JUL 2011

DOI: 10.1002/14651858.CD008926.pub2


How to Cite

Mao C, Yang ZY, He BF, Liu S, Zhou JH, Luo RC, Chen Q, Tang JL. Toremifene versus tamoxifen for advanced breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD008926. DOI: 10.1002/14651858.CD008926.pub2.

Author Information

  1. 1

    The Chinese University of Hong Kong, Division of Epidemiology, School of Public Health and Primary Care, Hong Kong, China

  2. 2

    Nanfang Hospital, Southern Medical University, Department of Oncology, Guangzhou, Guangdong, China

  3. 3

    School of Public Health and Tropical Medicine, Southern Medical University, Department of Epidemiology, Guangzhou, China

  4. 4

    The Chinese University of Hong Kong, School of Public Health and Primary Care, New Territories, Hong Kong, China

*Jin Ling Tang, School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Satin, New Territories, Hong Kong, China. jltang@cuhk.edu.hk.

Publication History

  1. Publication Status: New
  2. Published Online: 11 JUL 2012

SEARCH

  1. Current Version

    Toremifene versus tamoxifen for advanced breast cancer

    Chen Mao, Zu-Yao Yang, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Rong-Cheng Luo, Qing Chen and Jin Ling Tang

    Article first published online: 11 JUL 2012 | DOI: 10.1002/14651858.CD008926.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Toremifene versus tamoxifen for advanced breast cancer

    Chen Mao, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Li-Xin Qiu, Rong-Cheng Luo and Qing Chen

    Article first published online: 19 JAN 2011 | DOI: 10.1002/14651858.CD008926